Navigation Links
Lilly Discontinues One of Three Phase 3 Rheumatoid Arthritis Registration Studies for Tabalumab
Date:12/13/2012

s and diabetic nephropathy.

About Lilly's Pipeline

Lilly currently has a number of unique potential medicines in its Phase 3 clinical development pipeline, representing a variety of therapeutic areas including diabetes (four), cancer (three), neuroscience (two), autoimmunity (three) and cardiovascular (one).  To learn more about the molecules in Lilly's clinical development pipeline, please visit Lilly's interactive pipeline website available at Lilly.com/pipeline.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

This press release contains forward-looking statements about the potential of tabalumab for the treatment of rheumatoid arthritis and lupus, and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that the compound will receive regulatory approval, or that it will be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

P-LLY

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lilly Provides Update on Next Steps for Solanezumab
2. Lilly to Expand Indianapolis Insulin Manufacturing Operations
3. Lilly Names Melissa Barnes Chief Ethics and Compliance Officer and Senior Vice President; Announces Retirement of Anne Nobles
4. Lilly Celebrates 18th Consecutive Year as One of Working Mothers 100 Best Companies
5. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
6. Lilly Announces Results From Lung Cancer Study
7. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
8. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
9. U.S. Court of Appeals Upholds Validity of Lillys Alimta Compound Patent
10. Lilly Revises 2012 Reported Guidance to Reflect Income from Early Payment of Amylin Obligations
11. Lilly Announces Study Results Regarding Postmenopausal Women with Back Pain Caused by Vertebral Fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...   EVO Aesthetic Center and Wellness Spa ... aesthetics in Lakeway, Texas and ... Astanza Duality laser. The medical spa is focused on ... and laser procedures. Their addition of the Astanza Duality ... to their tattoo regret. "The large number ...
(Date:7/2/2015)... , July 2, 2015 Pharma Major ... in ZAO "Biocom" in Russia subject ... the Russian pharmaceutical market which recorded RUB 765 billion in ... markets in the world in 2014 (IMS Health). For over ... expected to continue with this trend, projecting Russia ...
(Date:7/2/2015)... 2015 The report "Silage Inoculants ... (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type ... Silage Inoculants & Enzymes Market is expected to reach ... from 2015 to 2020. Browse 75 ... 194 P ages and an in-depth ...
Breaking Medicine Technology:EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... solutions and management consulting services to the federal government, has announced they are ... Indefinite-Quantity (IDIQ), Business Management Office Support Services (BMOSS) contract not to exceed $250 ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Hand sanitizers have ... current summer flu season, according to fresh water advocate and radio host Sharon Kleyne, ... hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied correctly and ...
(Date:7/2/2015)... Mountain Home, AR (PRWEB) , ... July 02, 2015 , ... ... to military families through their annual “Dog Tag” campaign. On Tuesday, July 7, ... For The Warriors® for nearly $800,000. Hope For The Warriors® is a national nonprofit ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... , Dr. Irmgard Neuper is the new General Manager at Catalent’s Schorndorf facility, ...
(Date:7/2/2015)... ... 02, 2015 , ... A team of quality control (QC) experts at GE ... QC laboratory for enhanced workflow. Now, Dr. Dunne’s lab has set a lofty goal: ... Healthcare Diagnostic Imaging network. , Join the team members for a new, free ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3
... -- Low doses of a drug used to prevent ... considerably reduces hot flashes in patients undergoing anti-hormonal treatment, ... the result of a study carried out by North ... in Rochester, Minn. ,In presenting results of ...
... can feel a bit relaxed now. Genosis Inc, a US ... Fertell. The test has his and hers components ... device to measure the concentration of motile sperm, and a ... of egg quality. ,The availability of the two-in-one ...
... D.C. At the 54th Annual Meeting of SNM, ... nuclear medicine professionals, German researchers stated that ... accurately identifies patients responding to chemotherapy for esophageal ... to apply PET results from early metabolic response ...
... Organizations (AAPPO) is launching a new initiative to help ... patients diagnosed with diabetes as well as encourage ... AAPPO today kicked off its new ACT on Diabetes ... better care, and empower their patients to Take charge ...
... HIVmirror LLC, a Philadelphia-based company offering HIV positive ... announcing the launch of their innovative HIV progression ... its user-friendly Web site (http: www.hivmirror.com), empowers modern ... genetic code and its role in their potential ...
... ability to get in and see the doctor will be ... physicians, according to a new survey released today by ... national campaign to stop next year's 10 percent cut, was ... bleak picture for the future of Medicare. ,"The ...
Cached Medicine News:Health News:Hot Flashes in Men Treated for Prostate Cancer Reduced by Non-hormonal Drug 2Health News:Hot Flashes in Men Treated for Prostate Cancer Reduced by Non-hormonal Drug 3Health News:Fertility Test at Home Possible With a New Kit 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2Health News:AAPPO Launches ACT on Diabetes Initiative to Promote Improved Diabetes Care 2Health News:HIVmirror, LLC Launching Breakthrough Genetic Product for HIV Positive Consumer 2Health News:New AMA Survey Finds Medicare Cuts Will Hurt Seniors 2Health News:New AMA Survey Finds Medicare Cuts Will Hurt Seniors 3
... The BD Macro-Vue RPR (Rapid ... and Tear-drop Tests are nontreponemal testing ... syphilis described in A Manual of ... in this manual are the most ...
Rapid Plasma Reagin (RPR) set is a non-treponemal flocculation test that is,used for the qualitative and semi-quantitative determination of reagin,antibodies in serum or plasma from persons with syph...
Enzyme Immunoassay for the quantitative ( qualitative 0020, on request) determination of IgG Class antibodies to Rubella virus....
Donor Screen & Confirmation Kit...
Medicine Products: